Clinically proven weight loss with GLP-1 medications
Join thousands who have achieved lasting weight loss with prescription GLP-1 treatments. Board-certified physicians create personalized plans tailored to your body and goals.
Important Safety Information
WARNING: THYROID C-CELL TUMORS. In animal studies, GLP-1 receptor agonists including tirzepatide and semaglutide caused thyroid C-cell tumors. It is not known whether these medications cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. Do not use if you or your family have a history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Common side effects include nausea, diarrhea, vomiting, constipation, and stomach pain. These medications are not for people with type 1 diabetes. See full safety information.
How these medications help you lose weight
GLP-1 receptor agonists mimic natural hormones that regulate appetite, blood sugar, and metabolism — helping you feel full sooner and reduce cravings.
Appetite Regulation
Works in the brain's appetite center, reducing hunger signals and helping you feel satisfied with smaller portions naturally.
Metabolic Improvement
Improves insulin sensitivity, reduces blood sugar spikes, and helps your body process food into energy rather than storing it as fat.
Sustained Results
Clinical trials demonstrate patients maintain significant weight loss over 68-88 weeks, with continued improvements in blood pressure and cholesterol.
Proven results from randomized controlled trials
In head-to-head studies, patients on GLP-1 medications lost 4-6x more weight compared to diet and exercise alone. Results typically begin within the first 4 weeks of treatment.
See If I QualifySources: SURMOUNT-1, STEP 1, SCALE trials. Individual results may vary. Past results do not guarantee future outcomes.
How GLP-1 medications compare
Results from major randomized controlled trials directly comparing medication effectiveness.
SURMOUNT-1: 72-week, randomized, double-blind, placebo-controlled trial. N=2,539 adults with BMI ≥30 or BMI ≥27 with weight-related comorbidity. All groups received lifestyle intervention. Individual results may vary.
SURMOUNT-5: 72-week, open-label, head-to-head trial. N=751 adults with BMI ≥30 or BMI ≥27 with comorbidity. Both medications used at maximum tolerated doses. Individual results may vary.
Ranges reflect results across multiple trials (SURMOUNT, STEP, SCALE, SUSTAIN). Actual results depend on dose, duration, individual physiology, and adherence. All trials included lifestyle intervention.
Sustained weight loss over time
3 steps to begin your weight loss journey
Check Eligibility
Answer a few quick questions about your health history and weight loss goals. Takes under 60 seconds.
Physician Consultation
Meet with a board-certified physician via telehealth. They'll review your profile and create a personalized treatment plan.
Medication Delivered
If prescribed, your medication ships directly to your door. Ongoing clinical support and check-ins included.
See if you may qualify in 60 seconds
Answer a few questions to determine if GLP-1 medication may be appropriate for you. This is not a medical diagnosis.
Questions to discuss with your physician
Being prepared helps you get the most from your consultation. Here are topics our physicians commonly address.
Real results from real patients
"I lost 47 pounds in 8 months. The weekly injections became routine quickly, and the appetite reduction was genuinely life-changing. I finally feel in control of my relationship with food."
"After years of yo-yo dieting, this actually worked. My physician was supportive throughout, the medication was simple to administer, and the results genuinely speak for themselves."
"The consultation process was straightforward and the physician genuinely listened to my concerns. Three months in and down 28 pounds with more energy than I've had in years."